Somewhere inside your mouth, hidden beneath bone and tissue, a secret has been sitting for your entire life. You were born with it. Your dentist probably never mentioned it. And until recently, no one knew how to wake it up.
Join a community of 14,000,000+ Seekers!
Subscribe to unlock exclusive insights, wisdom, and transformational tools to elevate your consciousness. Get early access to new content, special offers, and more!
A team of Japanese researchers believes they have found the key. After nearly two decades of development and successful animal studies, they are preparing to test a drug on humans that could do something once considered impossible. If it works, adults who have lost teeth may never need implants or dentures again. Instead, they might simply grow new ones.
September marks the beginning of human trials at Kyoto University and Kitano Hospital in Japan. And while the science behind the drug involves genetics and molecular biology, the story behind it is far more human. It is a story about patience, a stubborn idea, and a researcher who refused to let go of a dream.
How a Single Protein Holds Your Teeth Hostage

Every biological process in the body runs on signals. Some signals tell cells to grow. Others tell them to stop. When it comes to teeth, a protein called uterine sensitization-associated gene-1, or USAG-1, acts as a biological stop sign. Once your adult teeth come in, USAG-1 shuts down further tooth development. It locks the door and throws away the key.
Dr. Katsu Takahashi, head of dentistry and oral surgery at Medical Research Institute Kitano Hospital in Osaka, spent years studying how tooth growth works at a genetic level. His team zeroed in on USAG-1 as a primary target. If they could block the protein, they reasoned, new teeth might be free to develop.
So they built a drug designed to inhibit the inhibitor. Rather than forcing teeth to grow through some external mechanism, the treatment simply removes the barrier that prevents growth from happening on its own. It is a surprisingly elegant concept, and it worked beautifully in animals.
From Lab Mice to Full Grins
Before any drug reaches a human mouth, it must prove itself in animals. Dr. Takahashi’s team began with mice. A 2021 study published in Scientific Reports showed that applying USAG-1-targeting small interfering RNA (siRNA) to genetically modified mice could rescue tooth development that had been stopped by the absence of another gene called Runx2. Mice that should have had no teeth at all began growing them after treatment. Separate work showed that ferrets also responded well, developing new teeth they otherwise would not have had.
By 2023, a follow-up paper in Regenerative Therapy confirmed the results and went further, suggesting that anti-USAG-1 antibody treatment in mice could represent a breakthrough for human application. About 1 percent of people worldwide live with anodontia, a genetic condition that prevents a full set of teeth from growing. For the first time, researchers saw a realistic path toward helping them.
Humans Already Carry a Hidden Third Set of Teeth

Here is where the story takes its most surprising turn. According to Dr. Takahashi’s earlier research, humans are not limited to just two sets of teeth. A third set already exists inside the mouth as undeveloped buds, dormant and waiting.
Most people never activate these buds. But about 1 percent of the population does. People with hyperdontia grow more teeth than a standard set, which provides living proof that these extra buds are real. Dr. Takahashi believes the right genetic signal, delivered through the drug, could activate those buds in anyone.
In other words, the drug would not be creating teeth from nothing. It would be releasing teeth that the body already prepared but never allowed to develop. Your mouth has been holding onto a backup plan your whole life.
Who Gets Tested First, and What Happens Next
Phase one of human trials will enroll 30 men between the ages of 30 and 64, each missing at least one molar. Over 11 months, researchers will monitor safety and watch for early signs of tooth regrowth. If results prove promising, future phases will expand to include children ages 2 to 7 who were born with congenital tooth deficiencies, as well as older adults dealing with tooth loss from aging.
Dr. Takahashi has carried this vision for decades. His conviction runs deep, and he has spoken publicly about the personal weight of the work.
“The idea of growing new teeth is every dentist’s dream. I’ve been working on this since I was a graduate student. I was confident I’d be able to make it happen,” he told Japanese newspaper The Mainichi in 2023.
His confidence has been earned through years of incremental progress. But ambition alone does not produce results. Rigorous animal testing, careful study design, and peer-reviewed publications built the scientific foundation that made human trials possible.
A Long Road with a 2030 Finish Line

Even optimistic projections put a commercial tooth-regrowing drug several years into the future. Development began in 2005, and human trials are just now getting started. Regulatory approval, expanded testing, and manufacturing all stand between the current moment and widespread availability.
If everything goes well, general use could begin around 2030. Dr. Takahashi sees the drug fitting into a future where patients have more choices. “We’re hoping to see a time when tooth regrowth medicine is a third choice alongside dentures and implants,” he said.
For millions of people living with missing teeth due to genetics, accidents, or aging, that future cannot arrive soon enough. Dentures slip. Implants require surgery and can fail. A biological solution that lets the body do what it was always designed to do would change dentistry at its root.
Parallel Breakthroughs in Dental Regeneration

Dr. Takahashi’s team is not working in isolation. Other researchers around the world have been making progress in related areas of dental science, and their work adds weight to the possibility that biological tooth repair could become routine.
In 2018, scientists identified specific stem cell markers needed for regenerating dental pulp, the soft tissue inside a tooth. Understanding how these markers function opened doors for treating conditions like pulpitis and pulp necrosis, where the inner tooth tissue becomes damaged or dies.
By 2020, separate teams had shown that implanting human dental pulp stem cells into injured teeth could regenerate tissue, blood vessels, and sensory nerves. Root maturation continued even after treatment, suggesting the regenerated tissue behaved like natural pulp.
Work on bone regeneration has also progressed. Researchers discovered that a specific type of stem cell, called LepR+ cells, plays a key role in regrowing alveolar bone in tooth sockets after extraction. Others developed an adhesive hydrogel loaded with stem cells and microparticles to promote bone growth in the oral cavity. Together, these advances create a growing body of knowledge that supports the idea of full biological dental repair.
Nature’s Tooth-Replacement Champions

Humans are not the first species to benefit from tooth replacement. Nature has been running its own experiments for millions of years.
Elephants cycle through five or more sets of molars during their lifetime. As one tooth wears down from grinding tough vegetation, a new molar pushes forward to take its place. Sharks in the Carcharhiniform order go even further, shedding more than 30,000 teeth over a lifetime and constantly replacing the ones that fall out.
Humans lack these natural systems. Once an adult tooth is gone, it has always been gone for good. But the USAG-1 drug borrows from a similar regenerative principle found throughout the animal kingdom. It taps into a biological mechanism that already exists, one that the human body simply forgot how to use.
“Again, a medication that allows the body to regrow teeth could be life-changing for people affected by tooth loss due to genetic disorders, accidental injuries, or aging,” the researchers noted when discussing the broader impact of their work.
What Regrowing Teeth Says About Being Human
Few discoveries force us to reconsider what a human body can do quite like learning that dormant tooth buds already sit inside our mouths, waiting for permission to grow. For decades, losing a permanent tooth meant accepting a permanent gap or settling for an artificial replacement. Now, the possibility of a third set of teeth challenges a long-held belief about the fixed limits of human biology.
On a deeper level, the research reflects something about how humans approach boundaries that seem absolute. Dr. Takahashi spent his entire career chasing an idea many considered a fantasy. From graduate school to clinical trials, his work moved through decades of quiet, unglamorous progress before reaching a moment that could reshape modern dentistry. Such patience suggests that the greatest breakthroughs often grow from a stubborn refusal to accept old limitations.
For everyday readers, the meaning may be simpler but no less powerful. If the human body already carries the seeds of regeneration, what else might be lying dormant, waiting for the right signal? Tooth regrowth sits at the intersection of biology and human ambition, a reminder that our bodies and our willingness to push past assumed boundaries may hold far more potential than we ever imagined. Sometimes the answer is not out there somewhere. Sometimes it has been inside us all along.







